法国巨细胞动脉炎的特征与管理:基于国家医疗保险索赔数据的研究
在117例新发GCA患者中,74.4%为女性,平均年龄77.6岁;仅51.3%行颞动脉活检,84.3%仅使用糖皮质激素,最常用的激素节约剂为甲氨蝶呤(12.0%)。
要点
- 法国≥50岁人群GCA年发病率为7-10/10万人。
- 新发GCA患者中女性占74.4%,平均年龄77.6岁。
- 84.3%患者仅用糖皮质激素,甲氨蝶呤为最常用激素节约剂(12.0%)。
核心结论
- 法国GCA年发病率为7-10/10万人(≥50岁人群),辅助药物(主要为甲氨蝶呤)仅用于少数患者。
主要发现
- 共识别241例GCA患者,年发病率为7-10/10万人(≥50岁人群)。
- 117例新发GCA患者中74.4%为女性,平均年龄77.6岁,平均随访2.2年。
- 索引日期后51.3%行颞动脉活检,29.1%行高分辨率多普勒超声。
- 全队列中84.3%仅使用糖皮质激素,最常用激素节约剂为甲氨蝶呤(12.0%)。
临床怎么用
- 法国真实世界数据显示GCA诊断中颞动脉活检使用率仅约一半,可能反映诊断向影像学技术转变。
- 绝大多数GCA患者仅接受糖皮质激素治疗,激素节约剂(主要为甲氨蝶呤)使用比例较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Few data are available on the epidemiology and management of GCA in real life. We aimed to address this situation by using health insurance claims data for France. METHODS: This retrospective study used the Echantillon Généraliste de Bénéficiaires (EGB) database, a 1% representative sample of the French national health insurance system. The EGB contains anonymous data on long-term disease status, hospitalizations and reimbursement claims for 752 717 people. Data were collected between 2007 and 2015. The index date was defined as the date of the first occurrence of a GCA code. Demographics, comorbidities, diagnostic tests and therapies were analysed. Annual incidence rates were calculated, and incident and overall GCA cases were studied. RESULTS: We identified 241 patients with GCA. The annual incidence was 7-10/100 000 people ⩾50 years old. Among the 117 patients with incident GCA, 74.4% were females, with mean age 77.6 years and mean follow-up 2.2 years. After the index date, 51.3% underwent temporal artery biopsy and 29.1% high-resolution Doppler ultrasonography. Among the whole cohort, 84.3% used only glucocorticoids. The most-prescribed glucocorticoid-sparing agent was methotrexate (12.0%). CONCLUSION: The incidence of GCA in France is 7-10/100 000 people ⩾ 50 years old. Adjunct agents, mainly methotrexate, are given to only a few patients. The use of temporal artery biopsy in only half of the patients might reflect a shift toward the use of imaging techniques to diagnose GCA.
引用
- Mahr A, Belhassen M, Paccalin M, et al. Characteristics and management of giant cell arteritis in France: a study based on national health insurance claims data. Rheumatology (Oxford). 2020. PMID: 31382293. doi:10.1093/rheumatology/kez251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。